Neuroimaging Software Solutions Provider QMENTA Announces Appointment of James Golando to Board of Directors

Boston, MA, September,  9, 2021  — QMENTA, Inc. announced today that James (Jim) Golando has been appointed to the company's Board of Directors. Mr. Golando joins the QMENTA Board of Directors with more than 30 years of experience in the pharmaceutical / biotech and services industries. Jim has overseen the operational and developmental planning and execution of  global clinical trials in oncology, respiratory, endocrine, anti-infectives, cardiology, and imaging. His expertise ranges from Phase I through late-stage development and  lifecycle management, with particular strengths in imaging clinical trials, clinical research, clinical operations, procurement/outsourcing, project/team leadership, and project management. 

Jim has held senior leadership positions as Chief of Operations at Ora Inc. and Median Technologies. Prior to that Jim was Vice President of Medical Affairs, Medical Imaging and Cardiovascular Services with BioClinica. Earlier leadership  positions included roles at Piramal Healthcare Ltd.; CoreLab Partners, Inc.; Schering Plough Research Institute; and Novartis Pharmaceuticals.

“As a highly respected and seasoned R&D executive, Jim’s extensive experience and network in the biopharma and CRO space, and in growing companies from an operational point of view is very valuable to QMENTA at this time. We look forward to Jim’s expert guidance particularly as we accelerate growth in our global Clinical Trials services with early stage biotechs to mid- and large pharmaceutical companies and leading CROs,” said Vesna Prchkovska, Ph.D., CEO and Co-founder at QMENTA. 

"I am very excited about joining the QMENTA Board," stated Mr Golando. "QMENTA’s unique focus on Neuroimaging and AI-powered cloud solutions to solve Neurological diseases coincides with key advances in biomarkers, crossing the blood brain barrier as well as unprecedented demand from patients and a redefined regulatory stance from FDA. I look forward to working with Board members and company management to achieve critical company milestones and ultimately make a difference in patient lives.”



QMENTA is on a mission to empower breakthroughs that make brain diseases a thing of the past through advanced neuroimaging analysis. The company’s AI-powered cloud digital platform streamlines big data aggregation, compliance, collaboration and analysis to improve outcomes for neurology research, clinical trials and clinical care faster and at lower cost and risk. Our expert Neuro Data Services significantly augment the value of complex neuroimaging, real world patient and clinical data making it highly usable. Clients include leading life sciences companies, CROs, research institutions, healthcare providers, imaging companies and AI developers. QMENTA is a privately held, venture backed company headquartered in Boston, Massachusetts.

The company was named “Best New Radiology Vendor” in 2017 by Aunt Minnie and was a European Winner for Accenture’s Healthtech Innovation Challenge and won the Sanofi Tech Lab challenge. Learn more at: